Oteracil is a chemoprotective agent often formulated as a potassium salt, primarily utilized as an adjunct to antineoplastic chemotherapy to mitigate gastrointestinal toxicity. By selectively inhibiting… Read more
Oteracil is a chemoprotective agent often formulated as a potassium salt, primarily utilized as an adjunct to antineoplastic chemotherapy to mitigate gastrointestinal toxicity. By selectively inhibiting the enzyme orotate phosphoribosyltransferase, it modulates the metabolism of fluoropyrimidine-based anticancer drugs, effectively reducing their side effects in normal gastrointestinal tissues. In pharmaceutical laboratories, high-quality reference standards of Oteracil and its related compounds are essential for rigorous analytical testing and quality control. These materials support accurate impurity profiling and method validation, ensuring the precise quantification of drug substances in complex pharmaceutical formulations. Laboratories also rely on these compounds to maintain compliance with established regulatory standards during the development and manufacturing of finished dosage forms. Stable isotope labelled versions of these substances may also be employed in advanced analytical studies to enhance the precision of detection and monitoring throughout the lifecycle of the drug product.